Acute drop in blood monocyte count differentiates NEC from other causes of feeding intolerance

J Remon1, R Kampanatkosol2, R R Kaul3

  • 11] Division of Neonatology, Department of Pediatrics, University of Illinois at Chicago, Chicago, IL, USA  [2] Center for Neonatal and Pediatric Gastrointestinal Disease, Department of Pediatrics, University of Illinois at Chicago, Chicago, IL, USA.

Abstract

Insights

A drop in blood monocyte concentration can serve as a novel biomarker for necrotizing enterocolitis (NEC) in very-low-birth-weight (VLBW) infants. This finding offers a new diagnostic approach for this serious neonatal condition.

Area of Science:

  • Neonatal Medicine
  • Immunology
  • Gastroenterology

Background:

  • Necrotizing enterocolitis (NEC) is a severe intestinal disease in premature infants.
  • Macrophage infiltration is a key feature of NEC, with intestinal macrophages originating from blood monocytes.
  • This study investigates the potential of blood monocyte levels as a biomarker for NEC.

Purpose of the Study:

  • To test the hypothesis that increased monocyte recruitment to the gut in NEC leads to a decrease in blood monocyte concentration.
  • To evaluate the diagnostic utility of blood monocyte counts for identifying NEC in very-low-birth-weight (VLBW) infants.

Main Methods:

  • Retrospective review of medical records for VLBW infants diagnosed with NEC (cases) and matched controls with feeding intolerance but no NEC.
  • Absolute monocyte counts (AMCs) were recorded and compared between groups.
  • Diagnostic accuracy of AMCs was assessed using receiver-operator characteristic (ROC) analysis.

Main Results:

  • AMCs were significantly lower in infants with stage II and III NEC compared to controls.
  • A drop in AMCs of >20% showed a sensitivity of 0.70 and specificity of 0.71 for diagnosing NEC.
  • ROC analysis indicated a diagnostic accuracy (area under the curve) of 0.76 for AMC values.

Conclusions:

  • A decrease in blood monocyte concentration is a novel and potentially useful biomarker for NEC in VLBW infants.
  • Monitoring AMCs may aid in the early detection and diagnosis of NEC.
  • This finding contributes to understanding NEC pathogenesis and developing diagnostic tools.